Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

This study has been completed.
Novo Nordisk A/S
The Danish Diabetes Association
Information provided by:
University of Copenhagen Identifier:
First received: July 5, 2007
Last updated: June 3, 2008
Last verified: June 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)